|
Volumn 31, Issue 5, 2012, Pages 321-343
|
Cancer testis antigens: A novel target in lung cancer
|
Author keywords
Biomarker; Cancer vaccine; CTA; Immunotherapy; Lung cancer
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CANCER TESTIS ANTIGEN;
CANCER VACCINE;
CYCLIC AMP DEPENDENT PROTEIN KINASE;
MELANOMA ANTIGEN;
MELANOMA ANTIGEN A1;
MELANOMA ANTIGEN A2;
MELANOMA ANTIGEN A3;
NY ESO 1 ANTIGEN;
PLACEBO;
SCP1 ANTIGEN;
SPERM PROTEIN 17;
SPO11 ANTIGEN;
TUMOR MARKER;
UNCLASSIFIED DRUG;
AMINO TERMINAL SEQUENCE;
ANTIGEN EXPRESSION;
ARTICLE;
CANCER ADJUVANT THERAPY;
CANCER CHEMOTHERAPY;
CANCER GROWTH;
CANCER IMMUNIZATION;
CLINICAL TRIAL (TOPIC);
DNA SEQUENCE;
EARLY DIAGNOSIS;
ENZYME PHOSPHORYLATION;
HUMAN;
IMMUNOGENICITY;
LARGE CELL CARCINOMA;
LUNG ADENOCARCINOMA;
LUNG CANCER;
LUNG CARCINOMA;
LUNG NON SMALL CELL CANCER;
LUNG SQUAMOUS CELL CARCINOMA;
MELANOMA;
OVARY CANCER;
PRIORITY JOURNAL;
PROTEIN DOMAIN;
PROTEIN FUNCTION;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
ANTIGENS, NEOPLASM;
CLINICAL TRIALS AS TOPIC;
CPG ISLANDS;
DNA METHYLATION;
EARLY DIAGNOSIS;
FEMALE;
GENE EXPRESSION REGULATION, NEOPLASTIC;
HUMANS;
IMMUNOTHERAPY;
LUNG;
LUNG NEOPLASMS;
MALE;
TESTIS;
TUMOR MARKERS, BIOLOGICAL;
|
EID: 84867818975
PISSN: 08830185
EISSN: 15635244
Source Type: Journal
DOI: 10.3109/08830185.2012.723512 Document Type: Article |
Times cited : (21)
|
References (0)
|